Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Atopic Dermatitis Symptoms

Research synthesisModerate evidenceMixed effect size4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies (2 RCTs, 2 reviews), all reported beneficial effects of Lactobacillus acidophilus L-92 on atopic dermatitis symptoms. The two RCTs showed large, statistically significant improvements, while the reviews reported moderate benefits. Evidence is strongest for adults and children with clinically diagnosed atopic dermatitis, primarily in Japanese populations.

  • Studied populations: Japanese adults and children with clinically diagnosed atopic dermatitis

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Additionally, only two primary RCTs (both in Japanese populations) have been conducted, and no dose or form data are available, limiting the specificity of recommendations.

Generated Jul 11, 2026
Doses used in studies
  • CFU/day: 1 (median 1, IQR 11) 1 study
4 of 4 papers
Back to top